Insiders Trades
Total declarations
Companies
▲ Purchases (16 ops.)
▼ Sales (6 ops.)
Latest filing published 26 Jun 2026 for Faeth Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleBrian C. Stephenson
Insider track record
Disclosed buys
16
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brian C. Stephenson: trading record in brief
Brian C. Stephenson discloses dealings in 2 companies, chiefly BridgeBio Pharma, Inc. and Faeth Therapeutics, Inc. The record holds 40 filings, for trades running from 16 May 2021 to 26 June 2026.
The open-market side counts 16 purchases alongside 6 sales for €3.4M. The totals do not cover 16 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 18 option exercises. So far in 2026, the count stands at 16 purchases and no sales.
None of the 16 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 26 June 2026 with an open-market purchase in Faeth Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brian C. Stephenson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,891 sharesCommon StockSEC:0001780030-26-000005:0
Canonical exit: 22 Sept 2026 (T+90)
3,000 sharesCommon StockSEC:0001780030-26-000005:1
Canonical exit: 22 Sept 2026 (T+90)
3,400 sharesCommon StockSEC:0001780030-26-000005:2
Canonical exit: 22 Sept 2026 (T+90)
100 sharesCommon StockSEC:0001780030-26-000005:3
Canonical exit: 22 Sept 2026 (T+90)
580 sharesCommon StockSEC:0001780030-26-000005:4
Canonical exit: 24 Sept 2026 (T+90)
4,212 sharesCommon StockSEC:0001780030-26-000005:5
Canonical exit: 24 Sept 2026 (T+90)
1,358 sharesCommon StockSEC:0001780030-26-000005:6
Canonical exit: 24 Sept 2026 (T+90)
100 sharesCommon StockSEC:0001780030-26-000005:7
Canonical exit: 24 Sept 2026 (T+90)
1,797 sharesCommon StockSEC:0001780030-26-000004:0
Canonical exit: 20 Sept 2026 (T+90)
1,118 sharesCommon StockSEC:0001780030-26-000004:1
Canonical exit: 20 Sept 2026 (T+90)
1,583 sharesCommon StockSEC:0001780030-26-000004:2
Canonical exit: 20 Sept 2026 (T+90)
3,329 sharesCommon StockSEC:0001780030-26-000004:3
Canonical exit: 20 Sept 2026 (T+90)
356 sharesCommon StockSEC:0001780030-26-000004:4
Canonical exit: 20 Sept 2026 (T+90)
6,836 sharesCommon StockSEC:0001780030-26-000004:5
Canonical exit: 21 Sept 2026 (T+90)
1,969 sharesCommon StockSEC:0001780030-26-000004:6
Canonical exit: 21 Sept 2026 (T+90)
425 sharesCommon StockSEC:0001780030-26-000004:7
Canonical exit: 21 Sept 2026 (T+90)
8,500 shares@ US$17.003.0% of flowCommon StockSEC:0000950170-25-029262:0
25,798 sharesCommon StockSEC:0000950170-25-023630:0
68,000 shares@ US$17.0023.8% of flowCommon StockSEC:0000950170-25-011242:0
4,156 shares@ US$22.41021.9% of flowCommon StockSEC:0000950170-24-129452:0
25,799 sharesCommon StockSEC:0000950170-24-128888:0
25,797 sharesCommon StockSEC:0000950170-24-099269:0
27,507 sharesCommon StockSEC:0000950170-24-061638:0
44,996 sharesCommon StockSEC:0000950170-24-017895:0
44,996 sharesCommon StockSEC:0001209191-23-056015:0
25 of 40 declarations
